Eloralintide for cardiovascular diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Oct 2026: Trial registered, NCT07900633

The trials

NCT07900633: A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

State
Not started
Phase
Phase 3
People
3,000 planned
Started
Dec 2026
Primary completion
Nov 2029
Arms
Eloralintide
Results
None posted
  1. 28 Oct 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.